Isaac Emon
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Isaac Emon has a total of 54 co-authors. Here are the top co-authors by number of shared publications:
- D. Robert Siemens
Department of Urology, Queen’s University, Kingston, Ontario, Canada
26 shared publications - Danielle Jenkins
Pathology and Molecular Medicine, Queen’s University, Kingston, Canada. 3
26 shared publications - David M. Berman
Department of Pathology and Molecular Medicine Queen's University Kingston Ontario Canada
26 shared publications - Eva Michaud
Division of Urology, Department of Surgery, McGill University Health Center, Montreal, Canada. 5
26 shared publications - Gwenaëlle Conseil
Department of Biomedical and Molecular Sciences, Queen’s University, Kingston, Canada. 1
26 shared publications - Jake Hamilton
Centre for Functional and Metabolic Mapping (CFMM), Robarts Research Institute, Western University, London, ON, Canada
26 shared publications
Latest Publications
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Figure S11 from Atypical B Cells Promote Cancer Progression and Poor Response to Bacillus Calmette-Guérin in Non–Muscle Invasive Bladder Cancer
BBN exposure and BCG treatment alters plasma immunoglobulin profiles in a sex differential manner.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S11 from Atypical B Cells Promote Cancer Progression and Poor Response to Bacillus Calmette-Guérin in Non–Muscle Invasive Bladder Cancer
BBN exposure and BCG treatment alters plasma immunoglobulin profiles in a sex differential manner.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Figure S6 from Atypical B Cells Promote Cancer Progression and Poor Response to Bacillus Calmette-Guérin in Non–Muscle Invasive Bladder Cancer
Splenic ABC expansion is enhanced by a combination of BBN exposure and BCG treatment.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S6 from Atypical B Cells Promote Cancer Progression and Poor Response to Bacillus Calmette-Guérin in Non–Muscle Invasive Bladder Cancer
Splenic ABC expansion is enhanced by a combination of BBN exposure and BCG treatment.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Figure S9 from Atypical B Cells Promote Cancer Progression and Poor Response to Bacillus Calmette-Guérin in Non–Muscle Invasive Bladder Cancer
B‐cell depletion alters expression profiles of immune regulatory genes in the bladder microenvironment.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S9 from Atypical B Cells Promote Cancer Progression and Poor Response to Bacillus Calmette-Guérin in Non–Muscle Invasive Bladder Cancer
B‐cell depletion alters expression profiles of immune regulatory genes in the bladder microenvironment.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Tables S1-S13 from Atypical B Cells Promote Cancer Progression and Poor Response to Bacillus Calmette-Guérin in Non–Muscle Invasive Bladder Cancer
Data from Atypical B cells promote cancer progression and poor response to Bacillus Calmette Guérin in non-muscle invasive bladder cancer
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Tables S1-S13 from Atypical B Cells Promote Cancer Progression and Poor Response to Bacillus Calmette-Guérin in Non–Muscle Invasive Bladder Cancer
Data from Atypical B cells promote cancer progression and poor response to Bacillus Calmette Guérin in non-muscle invasive bladder cancer
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Figure S8 from Atypical B Cells Promote Cancer Progression and Poor Response to Bacillus Calmette-Guérin in Non–Muscle Invasive Bladder Cancer
Immune infiltration in the bladder microenvironment after repeated BCG treatment and B‐cell depletion in BBN exposed mice.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S8 from Atypical B Cells Promote Cancer Progression and Poor Response to Bacillus Calmette-Guérin in Non–Muscle Invasive Bladder Cancer
Immune infiltration in the bladder microenvironment after repeated BCG treatment and B‐cell depletion in BBN exposed mice.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Figure S4 from Atypical B Cells Promote Cancer Progression and Poor Response to Bacillus Calmette-Guérin in Non–Muscle Invasive Bladder Cancer
Expansion of ABCs in the systemic and local bladder microenvironment.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S4 from Atypical B Cells Promote Cancer Progression and Poor Response to Bacillus Calmette-Guérin in Non–Muscle Invasive Bladder Cancer
Expansion of ABCs in the systemic and local bladder microenvironment.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Figure S5 from Atypical B Cells Promote Cancer Progression and Poor Response to Bacillus Calmette-Guérin in Non–Muscle Invasive Bladder Cancer
Effect of transient B‐cell depletion and BBN exposure on urothelium of BBN exposed female and male mice.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S5 from Atypical B Cells Promote Cancer Progression and Poor Response to Bacillus Calmette-Guérin in Non–Muscle Invasive Bladder Cancer
Effect of transient B‐cell depletion and BBN exposure on urothelium of BBN exposed female and male mice.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Figure S10 from Atypical B Cells Promote Cancer Progression and Poor Response to Bacillus Calmette-Guérin in Non–Muscle Invasive Bladder Cancer
Contour plots showing myeloid and T cell populations.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S10 from Atypical B Cells Promote Cancer Progression and Poor Response to Bacillus Calmette-Guérin in Non–Muscle Invasive Bladder Cancer
Contour plots showing myeloid and T cell populations.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Figure S3 from Atypical B Cells Promote Cancer Progression and Poor Response to Bacillus Calmette-Guérin in Non–Muscle Invasive Bladder Cancer
Tumor-adjacent TLS characterized using multiplex IF and NanoString GeoMx DSP.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S3 from Atypical B Cells Promote Cancer Progression and Poor Response to Bacillus Calmette-Guérin in Non–Muscle Invasive Bladder Cancer
Tumor-adjacent TLS characterized using multiplex IF and NanoString GeoMx DSP.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Figure S2 from Atypical B Cells Promote Cancer Progression and Poor Response to Bacillus Calmette-Guérin in Non–Muscle Invasive Bladder Cancer
Gating strategy for identifying different subsets of T cells.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S2 from Atypical B Cells Promote Cancer Progression and Poor Response to Bacillus Calmette-Guérin in Non–Muscle Invasive Bladder Cancer
Gating strategy for identifying different subsets of T cells.